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Psychosocial and cognitive function in children
with nephrotic syndrome: association with
disease and treatment variables
Panagiota Manti1, George Giannakopoulos2*, Elena Giouroukou2, Helen Georgaki-Angelaki3,
Constantinos J Stefanidis4, Andromahi Mitsioni4, Nikolaos Stergiou3, Constantinos Mihas2, George P Chrousos5,
Maria Alexandra Magiakou5† and Gerasimos Kolaitis2†
Abstract
Background: To investigate possible differences in emotional/behavioral problems and cognitive function in
children with nephrotic syndrome compared to healthy controls and to examine the effect of disease-specific and
steroid treatment-specific characteristics on the abovementioned variables.
Methods: Forty-one patients with nephrotic syndrome (23 boys, age range: 4.4-15.2 years) and 42 sex- and
age-matched healthy control subjects (20 boys, age range: 4.1-13.4 years) were enrolled in the study. Disease
(severity, age of diagnosis, duration) and steroid treatment (total duration, present methylprednisolone dose and
duration of present dose) data were collected. In order to assess children’s emotional/behavioral problems, the
Child Behavior Checklist was administered. The Wechsler Intelligence Scale for Children – Third Edition was
administered to assess Full-Scale, Verbal, and Performance intelligence quotient (IQ) scores.
Results: The patients presented with more internalizing problems (P = 0.015), including withdrawal (P = 0.012) and
somatic complaints (P = 0 .011), but not more anxiety/depression or externalizing problems. A significant association
was found between severity of disease and somatic complaints (P = 0.017) as well as externalizing problems
(P = 0.030). Years of illness were significantly more in those presenting with abnormal anxiety/depression (P = 0.011).
Duration of steroid medication was significantly higher among those presenting with abnormal anxiety/depression
(P = 0.011) and externalizing problems (P = 0.039). IQ was not associated significantly with disease or steroid
treatment variables.
Conclusions: Psychosocial factors and outcomes may be important correlates of children’s nephrotic syndrome
and potential targets of thorough assessment and treatment.
Keywords: Children, Cognitive, Nephrotic syndrome, Psychosocial, Steroids
Background
It has been recognized that children with nephrotic
syndrome often experience significant emotional and
behavioral problems, especially those with frequent
relapses, steroid dependence, steroid resistance, or maternal
distress [1]. However, the evidence is rather limited. Higher
levels of anxiety, depression, aggression, and inattention in
children with nephrotic syndrome compared to healthy
controls have been reported in previous studies [2-7]. A
prospective study [8] found negative behavioral changes in
children with nephrotic syndrome during periods of
relapse. Nevertheless, it is very difficult to differentiate a
disease-specific effect as opposed to a treatment effect on
emotional and behavioral health, since all children with
nephrotic syndrome are treated with steroids at diagnosis.
Studies in pediatric patients treated with oral, inhaled, and
intravenous steroids indicate that adverse psychological side
effects can occur at any point during treatment [8-13]. It
has been suggested that children with nephrotic syndrome
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may be particularly susceptible to the side effects of steroids
because of the increased free serum prednisolone levels
measured during periods of hypoalbuminemia [8]. One
study [2] showed that children receiving high-dose oral
steroid treatment for nephrotic syndrome experienced
worsening behavioral changes. However, another larger
study [4] did not detect any association between steroid
treatment and behavior abnormality. In the present
study, we tried to investigate possible differences in
emotional/behavioral problems and cognitive function
in children with nephrotic syndrome compared to healthy
controls and to examine the effect of disease-specific and
treatment-specific characteristics.
Methods
Participants and procedures
Forty-one patients with nephrotic syndrome (23 boys, age
range: 4.4-15.2 years) and 42 sex- and age-matched healthy
control subjects (20 boys, age range: 4.1-13.4 years)
were enrolled in the study. All patients were diagnosed
at the Pediatric Departments of “Aghia Sophia” and “P.
& A. Kyriakou” Children’s Hospitals, Athens, Greece,
and followed-up as outpatients at regular intervals since
diagnosis in the Pediatric Nephrology Departments of
either hospital. All were on steroid treatment for at least
4 consecutive months before entry. The 4-month period
was chosen arbitrarily as a determinant of chronic treat-
ment. The control subjects were healthy children evaluated
for growth and puberty in the Division of Endocrinology,
Metabolism, and Diabetes of the First Department of
Pediatrics of “Aghia Sophia” Children’s Hospital. The study
was approved by the Scientific and Ethics Committees of
“Aghia Sophia” and “P. & A. Kyriakou” Children’s Hospitals,
and all parents provided written informed consent before
entry of their children in the study.
Measures
Nephrotic syndrome was defined according to the
International Study of Kidney Diseases in Children (ISKDC)
[14]. Relapse was defined as proteinuria (Albustix > 2+)
for more than 3 consecutive days. Frequent relapsers
were defined according to the ISKDC criteria (more than
2 relapses in the initial 6 months after presentation
or > 4 per year during follow-up) [15]. Steroid dependency
was defined according to Arbeitsgemeinschaft fur
PaediatrischeNephrologie (APN) as at least 2 relapses
during alternate-treatment with prednisone or within 2
weeks of cessation [16]. The disease was characterized as
mild (< 2 relapses per year without alternative treatment
other than steroids), moderate (2–4 relapses per year
with alternative treatment) or severe (> 4 relapses per
year ± alternative treatment).
All patients and healthy control subjects were informed
about the study and an appointment was arranged for the
day of evaluation. The nephrologists provided the patients’
medical records with the detailed history. On the day of
evaluation, a detailed history was obtained and a clinical
examination was performed. The patients and their parents
were asked in detail about the disease characteristics, the
medications and doses given, the remission periods and
number of relapses, and the present steroid regimen and
dose used. The control subjects were also asked about their
previous history, and serious diseases or previous chronic
treatment with steroids represented exclusion criteria.
On clinical examination, systolic and diastolic blood
pressure, height, weight, and pubertal stage were precisely
determined in all children. The body mass index (BMI) was
calculated using the formula: weight (kilograms)/height
(meters) [2]. Pubertal staging was based on Tanner’s
criteria. Waist and hip circumferences were also recorded
and blood pressure was measured. Waist to hip ratio
(WHR) Standard Deviation score (SDS) was calculated
using Dutch age references [17]. Greek longitudinal
normative data were used as standards for the calculation
of height, weight and BMI SDS [18,19]. Parental educa-
tional level was collected through parents’ reports using the
International Standard Classification of Education (ISCED)
[20]. The original 7 educational levels were codified in the
analysis into 3 categories: primary school (categories 0, 1
and 2), secondary school (categories 3 and 4) and university
degree (categories 5 and 6).
In order to assess children’s emotional/behavioral
problems, the Child Behavior Checklist (CBCL) [21,22],
a 113-item parent-report checklist, was administered.
Parents rate the frequency of specific behaviors in their
children during the previous 6 months. The CBCL yields
the following factors: anxious/depressed, withdrawn,
somatic complaints, social problems, thought problems, at-
tention problems, delinquent behavior, aggressive behavior,
internalizing problems, externalizing problems, and total
problems. Higher T-scores reflect poorer functioning,
with T-scores < 65 indicating normal problems, 65–69
borderline problems and > 69 abnormal problems.
The Wechsler Intelligence Scale for Children – Third
Edition (WISC-III) was administered to assess Full-Scale,
Verbal and Performance intelligence quotient (IQ) scores
[23]. IQ scores for children younger than 6 years old were
measured by the Wechsler Preschool and Primary Scale of
Intelligence – Third Edition (WPPSI-III) [24].
Data analysis
All continuous variables are presented as median ±
interquartile range (75th -25th percentile, IQR) since
the majority of them deviated from normal distribution,
according to the results of Shapiro-Wilk test for normality.
All categorical variables are presented as absolute and
relative (percentage) frequencies. The Mann–Whitney
U test was used in order to evaluate the differences in
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continuous variables between different groups. Pearson’s
chi-square or Fisher’s exact statistics were used in order to
investigate potential associations between categorical vari-
ables. Spearman’s correlation coefficient was used in order
to assess the associations between continuous variables. All
tests were two-sided at a significance level of P < .05. Data
were analyzed using STATA™ statistical software (Version
9.0, Stata Corporation, College Station, TX 77845, USA).
Results
The disease and steroid treatment characteristics of the
patients are depicted in Table 1. Thirty-eight of the 41
patients (92.7%) were on alternate-day steroid treatment,
24/41 (58.5%) had steroid-dependent NS, and 22/41
(53.7%) were also on other immunosuppressive drugs
(five patients were on cyclosporine, four on cyclophospha-
mide, two on MMF, one on ergamisole, and 10 patients
were on combined immunosuppressive treatment with the
previously determined regimens). Fourteen, 16, and 11 pa-
tients had mild, moderate and severe disease, respectively.
The distribution of clinical and demographic charac-
teristics by group is shown in Table 2. Almost 1 in 5
parents (19.5%) of children with nephrotic syndrome had
a low educational level while all parents of the children in
the control group had at least a medium educational
level (P < 0.001). Children with nephrotic syndrome had
significantly higher BMI (P < 0.001), WHR (P = 0.002) and
systolic pressure SDS (P < 0.001) as well as significantly
lower body height SDS (P < 0.001) than controls, pre-
sumably due to the steroid treatment.
A positive trend between CBCL factors such as with-
drawn, somatic complaints, thought, internalizing, and
total problems and the presence of disease was noticed
(Table 3), since a significantly higher frequency of
abnormality (T-score > 69) was noticed in the patient
rather than in the control group in the aforementioned
variables (9.8% vs. 0%, 12.8% vs. 0%, 23.1% vs. 2.4%, 25.0%
vs. 2.5%, 32.1% vs. 7.7%, respectively). Verbal, performance
and full-scale IQ were significantly lower in the children
with nephrotic syndrome compared to the controls
(114.0 ± 26.0 vs. 117.0 ± 20.0, 110.0 ± 13.5 vs. 114.0 ± 23.0,
110.5 ± 19.0 vs. 120.0 ± 26.0, respectively).
In an attempt to adjust for the significantly different
distribution of educational level between patients and
controls, all of the variables that were found to differ
significantly (withdrawn, somatic complaints, thought
problems, internalizing problems, total problems, verbal,
performance and full-scale IQ) were re-evaluated separately
for each educational level (low level was not considered
since none of the controls reported such). In those children
whose parents had a medium educational level, no signifi-
cant difference was found in any variable except full-scale
IQ (patients: 110.5 ± 20.5, controls: 118.0 ± 20.0, P = 0.039).
When the educational level of the parents was high,
borderline/abnormal emotional/behavioral problems that
were significantly more frequent among patients compared
to controls were withdrawn (patients: 40%/0%, controls:
0%/0%, P = 0.036), somatic complaints (patients: 20%/20%,
controls: 0%/0%, P = 0.036), and internalizing problems
(patients: 0%/60%, controls: 11.1%/5.6%, P = 0.040).
Table 1 Disease and steroid treatment characteristics of
the patient group
Patients
n (%)
Severity of disease Mild 14 (34.1)
Moderate 16 (39.0)
Severe 11 (26.8)
Median IQR
Age at diagnosis (ys) 3.50 1.90
Duration of illness (ys) 3.00 4.60
Total duration of steroid medication (months) 31.00 44.00
Present methylprednisolone dose (mg/kg/day)* 0.16 0.19
Duration of present dose (days)** 38.00 99.00
IQR, Interquartile range (75th-25th percentile).
*18/41 were on methylprednisolone and 23/41 on prednisolone treatment.
The dose was homogenized using the appropriate equivalence.
** The steroid dose was often changed for better outcome.
Table 2 Clinical and demographic characteristics of the
patient and control groups
Group
Patients Controls
n (%) n (%) P
Sex Boys 23 (56.1) 20 (47.6) 0.440
Girls 18 (43.9) 22 (52.4)
Nationality Greek 35 (85.4) 39 (92.9) 0.313
Other 6 (14.6) 3 (7.1)
Parental
education
Low 8 (19.5) 0 (0.0) <0
.001
Medium 28 (68.3) 21 (52.5)
High 5 (12.2) 19 (47.5)
Pubertal stage Preadolescence 35 (85.4) 31 (73.8) 0.192
Adolescence 6 (14.6) 11 (26.2)
Median IQR Median IQR P
Age (ys) 7.08 4.75 9.04 4.00 0.146
WHR SDS 0.76 0.92 0.04 0.83 0.002
BMI SDS 0.55 1.29 −0.32 1.30 <0.001
Body weight SDS −0.05 1.27 −0.26 1.58 0.439
Body height SDS −1.18 1.31 0.17 1.71 <0.001
Systolic blood pressure SDS 1.15 1.36 −0.31 1.60 <0.001
Diastolic blood pressure SDS 0.64 0.90 0.47 1.40 0.436
IQR, Interquartile range (75th-25th percentile), WHR =Waist to hip ratio,
SDS = Standard deviation score, BMI, Body mass index.
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Regarding severity of disease and child emotional/
behavioral problems, a significant association was found
between somatic complaints and severity of disease. Forty
percent of those having a severe disease reported CBCL
somatic complaints T-scores > 69, while the corresponding
relative frequency was 7.7% in those having a mild disease
(P = 0.017). Those reporting CBCL externalizing problems
T-scores > 69 were 33.3% of those having a severe disease,
23.1% of those having a moderate disease, and 15.4% of
those having a mild disease, underlining the significant
association between the two aforementioned variables
(P = 0.030). None of the other CBCL factors (anxious/
depressed, withdrawn, social problems, thought problems,
attention problems, delinquent behavior, aggressive
behavior, internalizing problems, and total problems)
were significantly correlated with severity of disease.
From all the factors of the CBCL, years of illness differed
significantly only in those reporting anxiety/depression
T-scores > 69 (7.8 ± 3.3) compared to those reporting a
T-score < 65 (3.0 ± 3.9, P = 0.011). None of the child emo-
tional/behavioral problems as reported in CBCL T-scores
associated significantly with steroid dose/kg/day. Duration
of steroid medication differed among the T-score categories
of anxiety/depression (< 65: 31.0 ± 51.0, 65–69: 12.0 ±
2.0, > 69: 94.0 ± 51.0, P = 0.011) and among those of
externalizing problems (< 65: 31.0 ± 51.0, 65–69: 12.0 ±
2.0, > 69: 94.0 ± 51.0, P = 0.039).
Verbal, performance and full-scale IQ did not differ
significantly among the categories of severity of disease
(mild, moderate, and severe) and were not significantly
correlated with years of illness, steroid dose/kg/day, or
duration of steroid medication.
Discussion
Our findings suggest that children with nephrotic
syndrome may experience higher levels of emotional/
behavioral problems related to disease- and treatment-
specific variables. Based on the responses of the CBCL, the
patients presented with more internalizing problems, such
as withdrawal and somatic complaints than healthy
controls. However, unlike previous reports [2-7], no marked
differences were found between the two groups regarding
anxiety/depression or externalizing problems.
It is quite difficult to differentiate the effects of treatment
vs. the disease itself on behavior. When in remission, the
child with nephrotic syndrome may appear physically well,
but medical insistence on regular monitoring for protein-
uria is an ever-present reminder that there is an underlying
chronic medical condition, which may potentially relapse.
The negative impact of chronic illness on emotional/behav-
ioral development is well documented and epidemiologic
studies estimated that children with chronic illnesses are 2
to 2.4 times more likely to develop diagnosable psychiatric
and behavioral disorders [7]. Children in the present sample
Table 3 Emotional/behavioral problems and intelligence
quotient (IQ) scores of the patient and control groups
Group
Patients Controls
CBCL
T-scores
n (%) n (%) P
Anxious/depressed <65 29 (78.4) 37 (90.2) 0.330
65-69 5 (13.5) 2 (4.9)
>69 3 (8.1) 2 (4.9)
Withdrawn <65 31 (75.6) 40 (97.6) 0.012
65-69 6 (14.6) 1 (2.4)
>69 4 (9.8) 0 (.0)
Somatic complaints <65 31 (79.5) 41 (97.6) 0.011
65-69 3 (7.7) 1 (2.4)
>69 5 (12.8) 0 (.0)
Social problems <65 30 (81.1) 40 (95.2) 0.094
65-69 6 (16.2) 2 (4.8)
>69 1 (2.7) 0 (.0)
Thought problems <65 29 (74.4) 38 (92.7) 0.008
65-69 1 (2.6) 2 (4.9)
>69 9 (23.1) 1 (2.4)
Attention problems <65 36 (97.3) 41 (97.6) 0.999
65-69 1 (2.7) 1 (2.4)
>69 0 (.0) 0 (.0)
Delinquent behavior <65 28 (84.8) 32 (76.2) 0.289
65-69 3 (9.1) 9 (21.4)
>69 2 (6.1) 1 (2.4)
Aggressive behavior <65 30 (78.9) 38 (92.7) 0.243
65-69 3 (7.9) 1 (2.4)
>69 5 (13.2) 2 (4.9)
Internalizing problems <65 22 (61.1) 32 (80.0) 0.015
65-69 5 (13.9) 7 (17.5)
>69 9 (25.0) 1 (2.5)
Externalizing problems <65 20 (62.5) 30 (73.2) 0.513
65-69 5 (15.6) 6 (14.6)
>69 7 (21.9) 5 (12.2)
Total problems <65 18 (64.3) 31 (79.5) 0.027
65-69 1 (3.6) 5 (12.8)
>69 9 (32.1) 3 (7.7)
Median IQR Median IQR P
Verbal IQ 114.00 26.00 117.00 20.00 0.025
Performance IQ 110.00 13.50 114.00 23.00 0.015
Full-scale IQ 110.50 19.00 120.00 26.00 0.005
IQR, Interquartile range (75th-25th percentile), IQ, Intelligence quotient.
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with severe disease seemed to present more somatic
complaints and externalizing problems than did those
with mild or moderate disease. Similar results have
been previously reported, with frequent relapses being
associated with somatic complaints and externalizing/
aggressive behavior [1,5,8]. Moreover, the duration of the
illness was associated with more anxiety/depression
symptoms. This finding is in line with previous obser-
vations identifying duration of the disease as a strong
predictor of emotional problems [5]. The prolonged
need to take medications, frequent contacts with medical
professionals, interruptions in schooling and everyday
activities, and parents’ anxious concerns about the
course of the illness may be mechanisms through
which the illness duration increases children’s anxiety
and depression symptoms.
Among the treatment-specific variables examined in
the present analysis, duration of steroid treatment was
found to be significantly related to children’s anxiety/
depression and externalizing problems. This finding
may reflect the effect of the extended exposure to steroids
on the children’s physical appearance and fitness, as it was
reflected in the significant differences in the BMI, height,
and WHR between patients and controls in the present
sample. Changes in these crucial dimensions of children’s
self-image can affect their self-esteem and their peer
relationships (e.g. facing social exclusion or bullying)
leading to anxiety/depression and behavior problems.
Moreover, it could be hypothesized that anxiety/depression
problems may be partly induced by steroid effects on brain
regions (i.e. hippocampus and amygdala) involved in mood
regulation and in which corticosteroid receptors are densely
located. Also, externalizing problems, which were here
significantly associated both with duration of steroid
medication and severity of disease, may be attributable
to a trend of increased emotional liability and aggressive
behavior in nephrotic children under steroid medication
[8]. The abovementioned findings are in line with previous
literature indicating that insomnia, tearfulness, irritability,
argumentative behavior, and tiredness are more common
in children on steroids than controls [8-13]. On the
other hand, the present study did not manage to find
any associations between steroid dose and emotional/
behavioral abnormalities, which have been reported
elsewhere [2,5]. Moreover, previous reports have yielded
conflicting findings with some studies showing no associa-
tions [25,26] and other studies indicating diminished verbal
memory in high steroid dose (61.5 mg prednisolone/day)
groups compared to low dose (3–7 mg prednisolone/day)
groups [11,13]. In the present samples no associations were
found between steroid treatment characteristics and IQ
scores, with the exception of patients with medium parental
education level that showed lower full-scale IQ scores
compared to controls. However, it is difficult to judge
these differences, since low and high educational levels
are under-represented in the present sample, compared
to Greek community samples [27]. Furthermore, it should
be mentioned that the steroid doses administered at the
time of evaluation in the present sample were mostly low,
since most patients were in remission. Overall, the present
study did not manage to draw a definite conclusion
regarding the effect of steroids on the regulation of
behavior, mood, and cognitive functions among children
with nephrotic syndrome. The fact that, in the present
sample, no differences were observed between patients
and healthy controls regarding anxiety and externalizing
problems, in particular, although these problems were
associated with medication and disease characteristics
in the patient group, needs to be interpreted with
caution. This discrepancy may suggest that the absence
of any differences concerning anxiety and externalizing
problems may be due to the fact that the sample size
was rather small and/or the administered steroid doses
were mostly low, as previously mentioned. Further
research with a larger sample receiving higher steroid
doses (e.g. with patients being in relapse) is needed in
order to enhance the validity of this examination.
The present study contributes to previous research
mainly in two ways. First, it examined the associations of
several psychosocial factors and outcomes with pediatric
nephrotic syndrome providing a comprehensive picture
of this complex interplay. Second, it shed some light on
the relationship of the disease and treatment characteristics
with children’s cognitive functions as measured through
verbal and performance IQ scales, an issue that was
missing in pediatric nephrotic syndrome literature. The
findings reported here can offer some useful implications.
Addressing the psychosocial needs of children in the course
of nephrotic syndrome seems to be of importance in any
effective preventive and therapeutic intervention. More-
over, the role of prolonged exposure to the disease itself
and its treatment seem to be a possible target for future
research and psychosocial interventions.
The present findings should be interpreted in the context
of some limitations. First, the study was based only on
parent-reported children’s emotional/behavioral problems
that limit the interpretation of the results. Second, the study
did not examine the effect of socioeconomic status on the
reported differences, threatening generalizability of results.
Moreover, parents with low educational level were under-
represented in the study. Similarly, no definite conclusions
can be drawn regarding the effect of parental education on
the observed differences, since parents with low educational
level were under-represented in the present study. The
control group, in particular, did not include parents with
low education level, while the latter represents more than
one third of cases in nation-wide community samples.
This possible selection bias may be due to the fact that the
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control group was recruited from a health service for
growth and development evaluation, where families with
low educated parents more rarely seek help [27]. In
addition, the sample size was rather small, leading to a
low statistical power. Adjustment for multiple comparisons
was not performed due to the fact that our sample was
relatively small and many variables had to be tested. Last,
the cross-sectional design of the study did not allow us to
examine variations over time or make causal inferences.
Regardless of these limitations, the present study clearly
suggests that psychosocial factors and outcomes may be
important correlates of children’s nephrotic syndrome and
potential targets of thorough assessment and treatment.
Conclusions
Children with nephrotic syndrome presented with more
withdrawal problems and somatic complaints, but not
more anxiety/depression or externalizing problems
compared to their healthy counterparts. The severity
of disease was positively associated with more somatic
complaints as well as externalizing problems. Years of
illness were significantly more in those presenting with
abnormal anxiety/depression Duration of steroid medica-
tion was significantly higher among those presenting with
abnormal anxiety/depression and externalizing problems.
Addressing the psychosocial needs of children in the course
of nephrotic syndrome seems to be of importance in any ef-
fective preventive and therapeutic intervention. The role of
prolonged exposure to the disease itself and its treatment
seem to be a possible target for future research and psycho-
social interventions.
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